Gene Therapy Outlook 2020
Gene Therapy has shown tremendous growth in the past few years. The use of AAV (adeno-associated virus) and CAR-T cell immunotherapy has made success in the gene therapy segment in 2000s and in the present era. There are many ongoing clinical trials for the gene therapy and mostly the trials conducted are for cancer and neurological disorders. With the growing technologies, gene therapy has become an essential aspect in the research and treatment pattern.
Through this whitepaper DelveInsight is representing the present scenario of the gene therapy in 2020 covering the new marketed gene therapy products and latest ongoing clinical trials. With the ongoing clinical developments in the treatment segment, gene therapy has shown an exponential growth rate in the market. The United States is biggest contributor in both regional and global market. Second most prominent market is Europe and the third contributor is APAC regions such as China and Japan. With the expanding opportunities it is expected that gene therapy will impact the medical field and will revolutionize the clinical, pre-clinical, and other specialized methods in the future.
